SciELO - Scientific Electronic Library Online

vol.38 issue4Interruptions of pregnancy through geneticMaternal-perinatal outcome of patients with pre-eclampsia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Cubana de Obstetricia y Ginecología

Print version ISSN 0138-600X


FIGUEROA CALDERON, Isabel; SAAVEDRA MOREDO, Daymí; DE LA TORRES SIERES, Yudith  and  SANCHEZ LUEIRO, Mayra. Effectiveness of magnesium sulfate in pre-eclampsia treatment. Rev Cubana Obstet Ginecol [online]. 2012, vol.38, n.4, pp. 458-466. ISSN 0138-600X.

Introduction: eclampsia is a disease of human pregnancy, responsible for a significant increase in the rates of maternal and perinatal morbidity and mortality. Objective: to study the effectiveness of the use of magnesium sulfate in the treatment of pre-eclampsia. Methods: an intervention and evaluation study in health services was conducted from June 1st to December 31st, 2011. 98 pregnant women admitted to the Perinatal Care unit were the universe and sample of this study. They had been classified as pre-eclamptic. Results: 68.36 % of these women were 20-34 years old, 75.51 % were nulliparous. 2.04 % had oligoanuria as response to the drug. 100 % of these patients used hypotensive drugs and hydralazine was mostly used (63.25 %). More than 50 % delivered at the end of pregnancy with healthy weight of the product. 76.50 % of births occurred by cesarean. The most common maternal complication was hypertension, and neonatal depression at birth was present in 7.14 %. Conclusions: magnesium sulfate treatment was effective because it was able to reduce the number of pregnant women with eclampsia, when using prophylactically.

Keywords : magnesium sulfate; eclampsia and pre-eclampsia.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )